Zhejiang Xianju Pharmaceutical Co.,Ltd.’s Net Profit Rose 15.5% in First Three Quarters of 2022
Listen to the full version

Zhejiang Xianju Pharmaceutical Co.,Ltd. (浙江仙琚制药股份有限公司) (002332.SZ) reported a net profit of 532.7 million yuan in the first three quarters of 2022, up 15.5% year-on-year.
Meanwhile, the company posted 3.5 billion yuan in revenue, up 4.1% year-on-year.
At the end of the reporting period, it had 6.7 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 22%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR